These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7530827)

  • 41. Structural basis for stem cell factor-KIT signaling and activation of class III receptor tyrosine kinases.
    Liu H; Chen X; Focia PJ; He X
    EMBO J; 2007 Feb; 26(3):891-901. PubMed ID: 17255936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus.
    Chabot B; Stephenson DA; Chapman VM; Besmer P; Bernstein A
    Nature; 1988 Sep; 335(6185):88-9. PubMed ID: 2457811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase.
    Tan JC; Nocka K; Ray P; Traktman P; Besmer P
    Science; 1990 Jan; 247(4939):209-12. PubMed ID: 1688471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype.
    Woolford J; McAuliffe A; Rohrschneider LR
    Cell; 1988 Dec; 55(6):965-77. PubMed ID: 2849512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of erbB kinase activity and oncogenic potential by single point mutations in the glycine loop of the catalytic domain.
    Shu HK; Chang CM; Ravi L; Ling L; Castellano CM; Walter E; Pelley RJ; Kung HJ
    Mol Cell Biol; 1994 Oct; 14(10):6868-78. PubMed ID: 7935404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The unique insert of cellular and viral fms protein tyrosine kinase domains is dispensable for enzymatic and transforming activities.
    Taylor GR; Reedijk M; Rothwell V; Rohrschneider L; Pawson T
    EMBO J; 1989 Jul; 8(7):2029-37. PubMed ID: 2551672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of tyrosine residues Y705 and Y807 on the transforming potency of the v-fms oncogene product of feline sarcoma virus.
    Trouliaris S; Hadwiger-Fangmeier A; Heimann M; Tamura T
    Arch Virol; 1995; 140(1):179-86. PubMed ID: 7646343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. c-kit protein, a transmembrane kinase: identification in tissues and characterization.
    Majumder S; Brown K; Qiu FH; Besmer P
    Mol Cell Biol; 1988 Nov; 8(11):4896-903. PubMed ID: 2463468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia.
    Crosier PS; Ricciardi ST; Hall LR; Vitas MR; Clark SC; Crosier KE
    Blood; 1993 Aug; 82(4):1151-8. PubMed ID: 7688988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A minor tyrosine phosphorylation site located within the CAIN domain plays a critical role in regulating tissue-specific transformation by erbB kinase.
    Chang CM; Shu HK; Ravi L; Pelley RJ; Shu H; Kung HJ
    J Virol; 1995 Feb; 69(2):1172-80. PubMed ID: 7815495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion.
    Bargmann CI; Weinberg RA
    EMBO J; 1988 Jul; 7(7):2043-52. PubMed ID: 2901345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural alterations in the carboxyl-terminal domain of the BCRABL gene product activate its fibroblastic transforming potential.
    Shore SK; La Cava M; Yendapalli S; Reddy EP
    J Biol Chem; 1994 Feb; 269(7):5413-9. PubMed ID: 8106523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Genomic Structure of the Proto-Oncogene c-kit Encoded at the Murine White Spotting Locus.
    Chu TY; Besmer P
    J Biomed Sci; 1995 Jan; 2(1):36-45. PubMed ID: 11725039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deletions in the N-terminal coding region of the v-sis gene: determination of the minimal transforming region.
    Sauer MK; Hannink M; Donoghue DJ
    J Virol; 1986 Aug; 59(2):292-300. PubMed ID: 3525855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does Generic Cyclic Kinase Insert Domain of Receptor Tyrosine Kinase KIT Clone Its Native Homologue?
    Ledoux J; Tchertanov L
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of Ws mutant allele of rats: a 12-base deletion in tyrosine kinase domain of c-kit gene.
    Tsujimura T; Hirota S; Nomura S; Niwa Y; Yamazaki M; Tono T; Morii E; Kim HM; Kondo K; Nishimune Y
    Blood; 1991 Oct; 78(8):1942-6. PubMed ID: 1912577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Thrombopoietin produced molecularly-biologically].
    von dem Borne AE; Gerritsen WR
    Ned Tijdschr Geneeskd; 1995 Sep; 139(38):1922-7. PubMed ID: 7477531
    [No Abstract]   [Full Text] [Related]  

  • 58. Intratumoral heterogeneity of c-KIT mutations in a feline splenic mast cell tumor and their functional effects on cell proliferation.
    Hasegawa Y; Shosu K; Tsuji K; Shimoyama Y; Miyama TS; Baba K; Okuda M; Itamoto K; Igase M; Mizuno T
    Sci Rep; 2022 Sep; 12(1):15791. PubMed ID: 36138037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assignment of the horse mitochondrial glutamate oxaloacetate transaminase 2 (GOT2) and v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT) to horse chromosome 3 by in situ hybridization.
    Lear TL; Coogle LD; Bailey E
    Cytogenet Cell Genet; 1998; 82(1-2):112-3. PubMed ID: 9763675
    [No Abstract]   [Full Text] [Related]  

  • 60. A single nucleotide polymorphism in the bovine kit oncogene (Hardy-Zuckerman 4 feline sarcoma viral (v-kit) oncogene homolog).
    Grosz MD; Stone RT
    Anim Genet; 1999 Oct; 30(5):394. PubMed ID: 10582296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.